Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIANO: NI-0801 in Primary Biliary Cirrhosis
2011-001326-26Phase 2Terminated
- Sponsor
- Lightchain Bioscience
- Start
- Mar 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of NI-0801 in primary biliary cholangitis (PBC), sponsored by Lightchain Bioscience. Primary endpoint: Change in liver enzyme measurements from baseline to Week 12. Started Mar 2011; status: terminated.
02
Drugs
NI-0801
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on 2011-001326-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001326-26.